Cefixime Trihydrate 200 mg + Clavulanic Acid 125 mg Tablet | PCD Pharma Manufacturer & Supplier India | Trumac Healthcare
Cefixime Trihydrate 200 mg + Clavulanic Acid 125 mg Tablet
WHO-GMP Manufacturer & PCD Pharma Franchise Supplier in India
Form: Tablet
Class: Third-Gen Cephalosporin + Beta-Lactamase Inhibitor
✓ Pan-India Monopoly PCD
✓ 1 Brand Options
Pricing, brochure & monopoly territory within 24 hrs.
Our Cefixime Trihydrate 200 mg + Clavulanic Acid 125 mg Tablet Brand Options (1 option)
Trumac Healthcare manufactures and supplies the following Cefixime Trihydrate 200 mg + Clavulanic Acid 125 mg Tablet brands for PCD pharma distribution. Click any brand to view full specifications and packaging.
Cefixime Trihydrate 200 mg + Clavulanic Acid 125 mg Tablet is manufactured under WHO-GMP-certified conditions by Trumac Healthcare and supplied for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across India. Whether you are a PCD distributor, stockist or retail chemist, our Cefixime Trihydrate 200 mg + Clavulanic Acid 125 mg formulation comes with full quality assurance, regulatory documentation and reliable pan-India despatch.
Therapeutic Indications
- Acute pharyngitis and tonsillitis (streptococcal)
- Acute otitis media
- Acute exacerbations of chronic bronchitis
- Uncomplicated UTI and cystitis
- Uncomplicated gonorrhoea (single dose)
- Typhoid fever (uncomplicated)
- Beta-lactamase-producing bacterial infections
- Recurrent UTI with prior antibiotic exposure
- Complicated otitis media and sinusitis
Mechanism of Action
Cefixime binds penicillin-binding proteins (PBP-3) on gram-negative bacteria, inhibiting the final transpeptidation step of peptidoglycan synthesis. The result is bacterial cell wall destabilisation and osmotic lysis. Cefixime is resistant to many beta-lactamases produced by gram-negative organisms — distinguishing it from earlier cephalosporins. Clavulanic acid is a suicide-substrate inhibitor of beta-lactamases — it binds and inactivates the enzymes that bacteria use to destroy beta-lactam antibiotics, restoring cefixime's spectrum against resistant strains.
Dosage & Administration
- Adults: 1 tablet twice daily for 5–7 days.
Side Effects
- Diarrhoea (relatively common), nausea, abdominal pain, mild skin rash.
- Less common: hypersensitivity reactions, transient elevation of liver enzymes.
- Rare: pseudomembranous colitis, severe skin reactions, anaphylaxis.
- GI upset more common with clavulanate component.
Contraindications
- Hypersensitivity to cephalosporins.
- Severe penicillin allergy (cross-reactivity ~10%).
- Renal impairment requires dose adjustment.
- History of GI disease (caution).
- History of cholestatic jaundice with clavulanate.
Storage
Store below 30 °C in a dry place, protected from light and moisture.
PCD Pharma Franchise for Cefixime Trihydrate 200 mg + Clavulanic Acid 125 mg Tablet
- ✓ WHO-GMP certified manufacturing facility
- ✓ Pan-India monopoly distribution rights available
- ✓ Multiple pack sizes: 10 x 6 (Alu-Alu)
- ✓ Trade-friendly PTR / PTS margins
- ✓ Free promotional material on request
- ✓ Full DCGI documentation and quality certificates supplied
Trumac Healthcare offers 1 brand option for Cefixime Trihydrate 200 mg + Clavulanic Acid 125 mg Tablet — each available in different pack sizes with trade-friendly margins. View the brand-specific pages below for detailed specifications, MRPs and packaging options.
For PCD franchise opportunities, monopoly distribution rights, or third-party contract manufacturing of Cefixime Trihydrate 200 mg + Clavulanic Acid 125 mg Tablet, contact our business development team. WhatsApp +91 9041677932 or email info@trumachealthcare.net.
Frequently Asked Questions
Who is the manufacturer of Cefixime Trihydrate 200 mg + Clavulanic Acid 125 mg Tablet?
Trumac Healthcare is a WHO-GMP certified manufacturer of Cefixime Trihydrate 200 mg + Clavulanic Acid 125 mg Tablet in India. We supply our own brand range (see brand options above) and also offer third-party contract manufacturing for PCD distributors.
Is Cefixime Trihydrate 200 mg + Clavulanic Acid 125 mg Tablet available for PCD pharma franchise on monopoly basis?
Yes. We offer Cefixime Trihydrate 200 mg + Clavulanic Acid 125 mg Tablet for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across all districts of India. Contact our business development team for pricing and territory availability.
What pack sizes are available for Cefixime Trihydrate 200 mg + Clavulanic Acid 125 mg Tablet?
Available pack sizes include: 10 x 6 (Alu-Alu).
What is the MRP / trade price for Cefixime Trihydrate 200 mg + Clavulanic Acid 125 mg Tablet?
MRPs range from ₹1800 to ₹1800 across our brand variants. Trade-friendly PTR/PTS margins available on request — WhatsApp +91 9041677932 for current rates.
How do I place an order or franchise enquiry?
WhatsApp +91 9041677932 or email info@trumachealthcare.net with your enquiry. Our team will revert within 24 hours with full pricing, brochure and franchise terms.
Ready to start your PCD franchise for Cefixime Trihydrate 200 mg + Clavulanic Acid 125 mg Tablet?